Literature DB >> 35551

Generation of chemiluminescence by a particulate fraction isolated from human neutrophils. Analysis of molecular events.

L C McPhail, L R DeChatelet, R B Johnston.   

Abstract

A particulate fraction isolated from human neutrophils by homogenization, then centrifugation at 27,000 g, was demonstrated to generate chemiluminescence. This luminescence required the addition of reduced pyridine nucleotide and was very low in fractions from resting normal cells. Stimulation of neutrophils with opsonized zymosan, phorbol myristate acetate, or ionophore A23187 resulted in marked enhancement of the chemiluminescence measured in subsequently isolated particulate fractions. Stimulation did not boost the luminescence produced by fractions from cells of patients with chronic granulomatous disease. The chemiluminescence of particulate fractions from stimulated neutrophils was linear with increasing protein concentration, had a pH optimum of 7.0, and was higher with NADPH as substrate than with NADH. These results confirm previous studies suggesting that the enzyme system responsible for the respiratory burst in neutrophils is present in this fraction. The particulate fraction was used to examine the nature and origin of neutrophil luminescence by investigating the effect on this phenomenon of certain chemical and enzymatic scavengers of oxygen metabolites. Results suggest that the energy responsible for the luminescence of particulate fractions and, presumably, the intact cell, is derived from more than one oxygen species and that luminescence is a product of the interaction of these species and excitable substrates within the cell.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 35551      PMCID: PMC371999          DOI: 10.1172/JCI109347

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  The quenching of singlet oxygen by amino acids and proteins.

Authors:  I B Matheson; R D Etheridge; N R Kratowich; J Lee
Journal:  Photochem Photobiol       Date:  1975-03       Impact factor: 3.421

2.  Chemiluminescence induced by operation of iron-flavoproteins.

Authors:  L GREENLEE; I FRIDOVICH; P HANDLER
Journal:  Biochemistry       Date:  1962-09       Impact factor: 3.162

3.  Xanthine oxidase. III. Sulfite oxidation as an ultra sensitive assay.

Authors:  I FRIDOVICH; P HANDLER
Journal:  J Biol Chem       Date:  1958-12       Impact factor: 5.157

4.  On the mechanism of inhibition of xanthine oxidase by the substrate xanthine.

Authors:  B H HOFSTEE
Journal:  J Biol Chem       Date:  1955-09       Impact factor: 5.157

5.  Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes.

Authors:  S J Klebanoff
Journal:  Semin Hematol       Date:  1975-04       Impact factor: 3.851

6.  The mechanism of the activity-dependent luminescence of xanthine oxidase.

Authors:  E K Hodgson; I Fridovich
Journal:  Arch Biochem Biophys       Date:  1976-01       Impact factor: 4.013

7.  The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes.

Authors:  R B Johnston; B B Keele; H P Misra; J E Lehmeyer; L S Webb; R L Baehner; K V RaJagopalan
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

8.  Singlet oxygen production associated with enzyme-catalyzed lipid peroxidation in liver microsomes.

Authors:  M M King; E K Lai; P B McCay
Journal:  J Biol Chem       Date:  1975-08-25       Impact factor: 5.157

9.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

10.  Deficiency of NADPH oxidase activity in chronic granulomatous disease.

Authors:  L C McPhail; L R DeChatelet; P S Shirley; C Wilfert; R B Johnston; C E McCall
Journal:  J Pediatr       Date:  1977-02       Impact factor: 4.406

View more
  15 in total

1.  Inhibition of neutrophil oxidative metabolism by nimesulide.

Authors:  F Capsoni; E Venegoni; F Minonzio; A M Ongari; V Maresca; C Zanussi
Journal:  Agents Actions       Date:  1987-06

2.  Chemiluminescence of human neutrophils induced by soluble stimuli: effect of divalent cations.

Authors:  L R DeChatelet; P S Shirley
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

3.  Use of lipophilic probes of membrane potential to assess human neutrophil activation. Abnormality in chronic granulomatous disease.

Authors:  B E Seligmann; J I Gallin
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

4.  Influence of complement on the chemiluminescent response of human leukocytes to immune complex.

Authors:  S Löfgren; A Tärnvik; J Carlsson
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

5.  Phagocytic activities in neonatal monocytes.

Authors:  C P Speer; M Wieland; R Ulbrich; M Gahr
Journal:  Eur J Pediatr       Date:  1986-10       Impact factor: 3.183

6.  Acute and progressive lung injury after contact with phorbol myristate acetate.

Authors:  K J Johnson; P A Ward
Journal:  Am J Pathol       Date:  1982-04       Impact factor: 4.307

7.  Respiratory burst enzyme in human neutrophils. Evidence for multiple mechanisms of activation.

Authors:  L C McPhail; P M Henson; R B Johnston
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

8.  Generation of chemiluminescence by human neutrophils exposed to soluble stimuli of oxidative metabolism.

Authors:  M A Westrick; P S Shirley; L R DeChatelet
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

9.  [Effect of phorbolmyristate acetate and bacterial lipopolysaccharides on the luminal chemiluminescence of neutrophil granulocytes].

Authors:  C Eschenbach
Journal:  Klin Wochenschr       Date:  1983-05-02

10.  Lactoferrin enhances hydroxyl radical production by human neutrophils, neutrophil particulate fractions, and an enzymatic generating system.

Authors:  D R Ambruso; R B Johnston
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.